Models in the Era of Ozempic: Why Ultrathin Is Still in
It is true that the Food and Drug Administration’s approval of Ozempic for weight loss in 2021 coincided with the shrinking runway trend. However, Mr. Bonnouvrier of DNA Models said he believed something deeper was going on — that the swing away from body diversity was part of a general swing away from social progressivism….
Read More “Models in the Era of Ozempic: Why Ultrathin Is Still in” »